Drug-induced hematologic syndromes

Advances in Hematology

Volumn 2009, Issue , 2009, Pages

  Mintzer, David M ^a   Billet, Shira N ^a   Chmielewski, Lauren ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; ANTICOAGULANT AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; BENZOCAINE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DAPSONE; FLUDARABINE; ISOBUTYL NITRITE; ISONIAZID; LEVOFLOXACIN; LINEZOLID; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; PENICILLAMINE; PHENAZOPYRIDINE; PHENYTOIN; PRILOCAINE; PRIMAQUINE; PYRIMETHAMINE; RHESUS D ANTIBODY; RIBAVIRIN; SALAZOSULFAPYRIDINE; TEICOPLANIN; TRIENTINE; TRIMETHOPRIM; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ACUTE LEUKEMIA; ANEMIA; APLASTIC ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; DISSEMINATED INTRAVASCULAR CLOTTING; EOSINOPHILIA; ERYTHROCYTE APLASIA; HEMATOLOGIC DISEASE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERCOAGULABILITY; HYPOPROTHROMBINEMIA; IATROGENIC DISEASE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY FAILURE; LEUKOCYTOSIS; MEGALOBLASTIC ANEMIA; METHEMOGLOBINEMIA; MICROANGIOPATHY; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW; SIDEROBLASTIC ANEMIA;

EID: 77950862374     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2009/495863     Document Type: Review

References (95)

1. Arndt P. A., Garratty G., The changing spectrum of drug-induced immune hemolytic anemia Seminars in Hematology 2005 42 3 137 144 (Pubitemid 41019442)
2. Johnson S. T., Fueger J. T., Gottschall J. L., One centers experience: the serology and drugs associated with drug-induced immune hemolytic anemiaa new paradigm Transfusion 2007 47 4 697 702
3. Gaines A. R., Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho (D) immune globulin intravenous administration for immune thrombocytopenic purpura Blood 2005 106 5 1532 1537
4. Borthakur G., OBrien S., Wierda W. G. et al., Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximabincidence and predictors British Journal of Haematology 2007 136 6 800 805 (Pubitemid 46348418)
5. Beuter E., G6PD deficiency Blood 1994 84 3613 3636
6. McHutchison J. G., Manns M. P., Brown R. S. Jr., Reddy K. R., Shiffman M. L., Wong J. B., Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy American Journal of Gastroenterology 2007 102 4 880 889 (Pubitemid 46496635)
7. Coleman M. D., Coleman N. A., Drug-induced methaemoglobinaemia treatment issues Drug Safety 1996 14 6 394 405
8. Daly J. S., Hultquist D. E., Rucknagel D. L., Phenazopyridine induced methaemoglobinaemia associated with decreased activity of erythrocyte cytochrome b5 reductase Journal of Medical Genetics 1983 20 4 307 309
9. Ward K. E., McCarthy M. W., Dapsone-induced methemoglobinemia Annals of Pharmacotherapy 1998 32 5 549 553
10. Ash-Bernal R., Wise R., Wright S. M., Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals Medicine 2004 83 5 265 273 (Pubitemid 39258412)
11. Collins J. F., Methemoglobinemia as a complication of 20 benzocaine spray for endoscopy Gastroenterology 1990 98 1 211 213
12. Srikanth M. S., Kahlstrom R., Oh K. H., Fox S. R., Fox E. R., Fox K. M., Topical benzocaine (Hurricaine) induced methemoglobinemia during endoscopic procedures in gastric bypass patients Obesity Surgery 2005 15 4 584 590 (Pubitemid 40605089)
13. Kane G. C., Hoehn S. M., Behrenbeck T. R., Mulvagh S. L., Benzocaine-induced methemoglobinemia based on the Mayo Clinic Experience from 28, 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors Archives of Internal Medicine 2007 167 18 1977 1982
14. Scott J. M., Weir D. G., Drug-induced megaloblastic change Clinics in Haematology 1980 9 3 587 606
15. Bellou A., Aimone-Gastin I., De Korwin J.-D. et al., Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy Journal of Internal Medicine 1996 240 3 161 164 (Pubitemid 26308673)
16. Ruscin J. M., Page R. L. II, Valuck R. J., Vitamin B12 deficiency associated with histamine2-receptor antagonists and a proton-pump inhibitor Annals of Pharmacotherapy 2002 36 5 812 816
17. Alcindor T., Bridges K. R., Sideroblastic anaemias British Journal of Haematology 2002 116 4 733 743 (Pubitemid 34226991)
18. Sharp R. A., Lowe J. G., Johnston R. N., Anti-tuberculous drugs and sideroblastic anaemia British Journal of Clinical Practice 1990 44 12 706 707
19. Montpetit M. C., Shammo J. L., Loew J., Dunlap S., Pamboukian S. V., Heroux A., Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device Journal of Heart and Lung Transplantation 2004 23 9 1119 1122 (Pubitemid 39345658)
20. Condamine L., Hermine O., Alvin P., Levine M., Rey C., Courtecuisse V., Acquired sideroblastic anaemia during treatment of Wilsons disease with triethylene tetramine dihydrochloride British Journal of Haematology 1993 83 1 166 168 (Pubitemid 23030189)
21. Kandola L., Swannell A. J., Hunter A., Acquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis Annals of the Rheumatic Diseases 1995 54 6 529 530
22. Kitahara M., Cosgriff T. M., Harmon E., Sideroblastic anemia as a preleukemic event in patients treated for Hodgkins disease Annals of Internal Medicine 1980 92 625 627 (Pubitemid 10107552)
23. Young N. S., Calado R. T., Scheinberg P., Current concepts in the pathophysiology and treatment of aplastic anemia Blood 2006 108 8 2509 2519
24. Aksoy M., Erdem S., Dincol G., Bakioglu I., Kutlar A., Aplastic anemia due to chemicals and drugs: a study of 108 patients Sexually Transmitted Disease 1984 11 supplement 4 347 350 (Pubitemid 15188103)
25. Andrews R., Russell N., Aplastic anemia associated with a non-steroidal anti-inflammatory drug: relapse after exposure to another such drug British Medical Journal 1990 301 38 (Pubitemid 20210997)
26. Alnigenis M. N., Nalcaci M., Pekcelen Y., Atamer T., Sargin D., Possible etiologic factors in 151 Turkish patients with aplastic anemia American Journal of Hematology 2001 68 1 60 61 (Pubitemid 32738721)
27. Baumelou E., Guiguet M., Mary J. Y., Epidemiology of aplastic anemia in France: a case-control study Blood 1993 81 6 1471 1478
28. Smalling R., Foote M., Molineux G., Swanson S. J., Elliott S., Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge Biotechnology Annual Review 2004 10 237 249 (Pubitemid 39419994)
29. Tanaka N., Ishida F., Tanaka E., Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C The New England Journal of Medicine 2004 350 12 1264 1265 (Pubitemid 38339377)
30. Casadevall N., Nataf J., Viron B. et al., Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin The New England Journal of Medicine 2002 346 7 469 475 (Pubitemid 34441737)
31. Summers S. A., Matijevic A., Almond M. K., Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia Nephrology Dialysis Transplantation 2004 19 8 2137 2139 (Pubitemid 39139651)
32. Verhelst D., Rossert J., Casadevall N., Kruger A., Eckardt K.-U., Macdougall I. C., Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study The Lancet 2004 363 9423 1768 1771 (Pubitemid 38698380)
33. Bennett C. L., Luminari S., Nissenson A. R. et al., Pure red-cell aplasia and epoetin therapy The New England Journal of Medicine 2004 351 14 1403 1408 (Pubitemid 39288166)
34. Aster R. H., Bougie D. W., Drug-induced immune thrombocytopenia The New England Journal of Medicine 2007 357 6 580 587
35. Visentin G. P., Liu C. Y., Drug-induced thrombocytopenia Hematology/Oncology Clinics of North America 2007 21 4 685 696
36. Bougie D. W., Wilker P. R., Aster R. H., Patients with quinine-induced immune thrombocytopenia have both drug-dependent and drug-specific antibodies Blood 2006 108 3 922 927
37. von Drygalski A., Curtis B. R., Bougie D. W. et al., Vancomycin-induced immune thrombocytopenia The New England Journal of Medicine 2007 356 9 904 910 (Pubitemid 46339909)
38. Arepally G. M., Ortel T. L., Heparin-induced thrombocytopenia The New England Journal of Medicine 2006 355 8 809 817 (Pubitemid 44285586)
39. Wartenkin T. E., Heparin-induced thrombocytopenia Hematology/Oncology Clinics of North America 2007 21 589 607 (Pubitemid 47102555)
40. Aster R. H., Curtis B. R., Bougie D. W., Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors Seminars in Thrombosis and Hemostasis 2004 30 5 569 577
41. Pisoni R., Ruggenenti P., Remuzzi G., Drug-induced thrombotic microangiopathy: incidence, prevention and management Drug Safety 2001 24 7 491 501 (Pubitemid 32595762)
42. Zakarija A., Bennett C., Drug-induced thrombotic microangiopathy Seminars in Thrombosis and Hemostasis 2005 31 6 681 690 (Pubitemid 43063086)
43. Medina P. J., Sipols J. M., George J. N., Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Current Opinion in Hematology 2001 8 5 286 293 (Pubitemid 32826498)
44. Bennett C. L., Kim B., Zakarija A. et al., Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura. A report from the SERF-TTP Research Group and the RADAR Project Journal of the American College of Cardiology 2007 50 12 1138 1143 (Pubitemid 47381493)
45. Kojouri K., Vesely S. K., George J. N., Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes Annals of Internal Medicine 2001 135 12 1047 1051 (Pubitemid 33151026)
46. Tseeng S., Arora R., Reviews: aspirin resistance: biological and clinical implications Journal of Cardiovascular Pharmacology and Therapeutics 2008 13 1 5 12 (Pubitemid 351238288)
47. Shen Y.-M. P., Frenkel E. P., Acquired platelet dysfunction Hematology/Oncology Clinics of North America 2007 21 4 647 661
48. Mukherjee D., Nissen S. E., Topol E. J., Risk of cardiovascular events associated with selective COX-2 inhibitors Journal of the American Medical Association 2001 286 8 954 959 (Pubitemid 33010342)
49. Kearney P. M., Baigent C., Godwin J., Halls H., Emberson J. R., Patrono C., Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials British Medical Journal 2006 332 7553 1302 1305 (Pubitemid 44365384)
50. Kerr D. J., Dunn J. A., Langman M. J. et al., Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer The New England Journal of Medicine 2007 357 4 360 369 (Pubitemid 47124136)
51. Singh A. K., Szczech L., Tang K. L. et al., Correction of anemia with epoetin alfa in chronic kidney disease The New England Journal of Medicine 2006 355 20 2085 2098 (Pubitemid 44749317)
52. Bohlius J., Wilson J., Seidenfeld J. et al., Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients Journal of the National Cancer Institute 2006 98 10 708 714 (Pubitemid 43821788)
53. Vandenbroucke J. P., Rosing J., Bloemenkamp K. W. M. et al., Oral contraceptives and the risk of venous thrombosis The New England Journal of Medicine 2001 344 20 1527 1535 (Pubitemid 32429213)
54. Cushman M., Kuller L. H., Prentice R. et al., Estrogen plus progestin and risk of venous thrombosis Journal of the American Medical Association 2004 292 13 1573 1580 (Pubitemid 39314963)
55. Vogel V. G., Costantino J. P., Wickerham D. L. et al., Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial Journal of the American Medical Association 2006 295 23 2727 2741 (Pubitemid 43920726)
56. Howell A., Cuzick J., Baum M., Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer The Lancet 2005 365 60 62 (Pubitemid 40082147)
57. Rogers J. S. II, Murgo A. J., Fontana J. A., Raich P. C., Chemotherapy for breast cancer decreases plasma protein C and protein S Journal of Clinical Oncology 1988 6 2 276 281 (Pubitemid 18065931)
58. Saphner T., Tormey D. C., Gray R., Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer Journal of Clinical Oncology 1991 9 2 286 294
59. Pritchard K. I., Paterson A. H. G., Paul N. A., Zee B., Fine S., Pater J., Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer Journal of Clinical Oncology 1996 14 10 2731 2737 (Pubitemid 26329659)
60. Alberts S. R., Bretscher M., Wiltsie J. C., ONeill B. P., Mokri B., Witzig T. E., Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement Leukemia and Lymphoma 1999 32 5-6 489 496 (Pubitemid 29086363)
61. Payne J. H., Vora A., Thrombosis and acute lymphoblastic leukaemia British Journal of Haematology 2007 138 430 445 (Pubitemid 47063030)
62. Caruso V., Iacoviello L., Di Castelnuovo A. et al., Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients Blood 2006 108 7 2216 2222 (Pubitemid 44497502)
63. Palumbo A., Rajkumar S. V., Dimopoulos M. A. et al., Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma Leukemia 2008 22 2 414 423 (Pubitemid 351255436)
64. Chan Y. C., Valenti D., Mansfield A. O., Stansby G., Warfarin induced skin necrosis British Journal of Surgery 2000 87 3 266 272 (Pubitemid 30156350)
65. Warkentin T. E., Roberts R. S., Hirsh J., Kelton J. G., Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study Chest 2005 127 5 1857 1861 (Pubitemid 46218820)
66. Scappaticci F. A., Skillings J. R., Holden S. N. et al., Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab Journal of the National Cancer Institute 2007 99 16 1232 1239
67. Franchini M., Capra F., Nicolini N. et al., Drug-induced anti-factor VIIII antibodies: a systematic review Medical Science Monitor 2007 13 55 61 (Pubitemid 46557763)
68. Otis P. T., Feinstein D. I., Rapaport S. I., Patch M. J., An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations Blood 1974 44 6 771 781
69. Austin S., Cohen H., Antiphospholipid syndrome Medicine 2006 34 11 472 475 (Pubitemid 44882715)
70. Clauser S., Fischer A., Darnige L., Quinine-induced lupus anticoagulant, hypoprothrombinemia, and antiprothrombin antibodies American Journal of Hematology 2007 82 330 (Pubitemid 46564338)
71. Shevchuk Y. M., Conly J. M., Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 19661988 Reviews of Infectious Diseases 1990 12 6 1109 1126
72. Strom B. L., Schinnar R., Gibson G. A., Brennan P. J., Berlin J. A., Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case Pharmacoepidemiology and Drug Safety 1999 8 2 81 94 (Pubitemid 29201635)
73. Holbrook A. M., Pereira J. A., Labiris R. et al., Systematic overview of warfarin and its drug and food interactions Archives of Internal Medicine 2005 165 10 1095 1106 (Pubitemid 40720733)
74. Bhatt V., Saleem A., Drug-induced neutropeniapathophysiology, clinical features, and management Annals of Clinical and Laboratory Science 2004 34 2 131 137 (Pubitemid 38685904)
75. Tavassoli N., Duchayne E., Sadaba B. et al., Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals European Journal of Clinical Pharmacology 2007 63 3 221 228 (Pubitemid 46237580)
76. Andersohn F., Konzen C., Garbe E., Systematic review: agranulocytosis induced by nonchemotherapy drugs Annals of Internal Medicine 2007 146 9 657 665 (Pubitemid 351650522)
77. Chaiwatanatorn K., Lee N., Grigg A., Filshie R., Firkin F., Delayed-onset neutropenia associated with rituximab therapy British Journal of Haematology 2003 121 6 913 918 (Pubitemid 36760311)
78. Dale D. C., Fauci As., Guerry D., Wolff S. M., Comparison of agents producing a neutrophilic leukocytosis in man Journal of Clinical Investigation 1975 56 808 813
79. Shoenfeld Y., Gurewich Y., Gallant L. A., Pinkhas J., Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis American Journal of Medicine 1981 71 5 773 778 (Pubitemid 12192353)
80. Roath S., Choudhury D., Edwards J. G., Francis J. L., Gordon A., Neutrophil mobilization in lithium-induced neutrophilia Human Psychopharmacology 2004 2 237 241
81. Cohen P. R., Sweets syndromea comprehensive review of an acute febrile neutrophilic dermatosis Orphanet Journal of Rare Diseases 2007 2 1 34
82. Tefferi A., Patnaik M. M., Pardanani A., Eosinophilia: secondary, clonal and idiopathic British Journal of Haematology 2006 133 5 468 492
83. Tas S., Simonart T., Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update Dermatology 2003 206 4 353 356 (Pubitemid 36677029)
84. Robinson N., Giraud S., Saudan C. et al., Erythropoietin and blood doping British Journal of Sports Medicine 2006 40 supplement 1 i30 i34 (Pubitemid 44032628)
85. Mauritzson N., Albin M., Rylander L. et al., Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 19761993 and on 5098 unselected cases reported in the literature 19742001 Leukemia 2002 16 12 2366 2378 (Pubitemid 36067289)
86. Smith S. M., Le Beau M. M., Huo D. et al., Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Blood 2003 102 1 43 52 (Pubitemid 36759634)
87. Beaumont M., Sanz M., Carli P. M. et al., Therapy-related acute promyelocytic leukemia Journal of Clinical Oncology 2003 21 11 2123 2137 (Pubitemid 46606361)
88. Smith R. E., Bryant J., DeCillis A., Anderson S., Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience Journal of Clinical Oncology 2003 21 7 1195 1204 (Pubitemid 46894010)
89. Hershman D., Neugut A. I., Jacobson J. S. et al., Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy Journal of the National Cancer Institute 2007 99 3 196 205 (Pubitemid 47232608)
90. Patt D. A., Duan Z., Fang S., Hortobagyi G. N., Giordano S. H., Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk Journal of Clinical Oncology 2007 25 25 3871 3876 (Pubitemid 47477263)
91. Pedersen-Bjergaard J., Andersen M. K., Christiansen D. H., Therapy-related acute myeloid leukemia and myelodysplasia after high- dose chemotherapy and autologous stem cell transplantation Blood 2000 95 11 3273 3279 (Pubitemid 30428453)
92. Baker K. S., DeFor T. E., Burns L. J., Ramsay N. K. C., Neglia J. P., Robison L. L., New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors Journal of Clinical Oncology 2003 21 7 1352 1358
93. Roboz G. J., Bennett J. M., Coleman M. et al., Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma Leukemia Research 2007 31 8 1141 1144 (Pubitemid 46881086)
94. Lazarou J., Pomeranz B. H., Corey P. N., Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies Journal of the American Medical Association 1998 279 15 1200 1205 (Pubitemid 28193431)
95. Jha A. K., Kuperman G. J., Rittenberg E., Teich J. M., Bates D. W., Identifying hospital admissions due to adverse drug events using a computer-based monitor Pharmacoepidemiology and Drug Safety 2001 10 2 113 119 (Pubitemid 32590942)